DrugPatentWatch Database Preview

Magnesium chloride; sodium bicarbonate; sodium chloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for magnesium chloride; sodium bicarbonate; sodium chloride and what is the scope of patent protection?

Magnesium chloride; sodium bicarbonate; sodium chloride is the generic ingredient in two branded drugs marketed by Dialysis Sups and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Magnesium chloride; sodium bicarbonate; sodium chloride has four patent family members in four countries.

There are one hundred and forty-six drug master file entries for magnesium chloride; sodium bicarbonate; sodium chloride.

Summary for magnesium chloride; sodium bicarbonate; sodium chloride

International Patents:	4
US Patents:	1
Tradenames:	2
Applicants:	1
NDAs:	1
Drug Master File Entries:	146
Clinical Trials:	215
DailyMed Link:	magnesium chloride; sodium bicarbonate; sodium chloride at DailyMed

Recent Clinical Trials for magnesium chloride; sodium bicarbonate; sodium chloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Tongji Hospital	Phase 4
University of Pittsburgh	N/A
Guy's and St Thomas' NHS Foundation Trust	N/A

See all magnesium chloride; sodium bicarbonate; sodium chloride clinical trials

US Patents and Regulatory Information for magnesium chloride; sodium bicarbonate; sodium chloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dialysis Sups	NORMOCARB HF 35	magnesium chloride; sodium bicarbonate; sodium chloride	SOLUTION;INJECTION	021910-002	Jul 26, 2006		RX	Yes	Yes
Dialysis Sups	NORMOCARB HF 25	magnesium chloride; sodium bicarbonate; sodium chloride	SOLUTION;INJECTION	021910-001	Jul 26, 2006		RX	Yes	Yes			Y

Expired US Patents for magnesium chloride; sodium bicarbonate; sodium chloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Dialysis Sups	NORMOCARB HF 25	magnesium chloride; sodium bicarbonate; sodium chloride	SOLUTION;INJECTION	021910-001	Jul 26, 2006
Dialysis Sups	NORMOCARB HF 35	magnesium chloride; sodium bicarbonate; sodium chloride	SOLUTION;INJECTION	021910-002	Jul 26, 2006

International Patents for magnesium chloride; sodium bicarbonate; sodium chloride

Country	Patent Number	Estimated Expiration
Canada	2365787
European Patent Office	1347795
Australia	2620902
World Intellectual Property Organization (WIPO)	0249693

Supplementary Protection Certificates for magnesium chloride; sodium bicarbonate; sodium chloride

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1499331	C300615	Netherlands		PRODUCT NAME: NATRIUMSULFAAT, MAGNESIUMSULFAAT EN KALIUMSULFAAT; NAT. REGISTRATION NO/DATE: RVG 110863 20130417; FIRST REGISTRATION: BE 434323 20130220
1020461	300482	Netherlands		PRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMZOUT; NATIONAL REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: GB PL 17091/0263 - 0001 20101105
0984957	122012000051	Germany		PRODUCT NAME: KOMBINATIONSPRODUKT UMFASSEND NAPROXEN UND ESOMEPRAZOL-MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 85145.00.00 20120202; FIRST REGISTRATION: GROSSBRITANNIEN PL 17901/0263 - 0001 20101105
0124495	SPC/GB01/006	United Kingdom		PRODUCT NAME: ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE; REGISTERED: SE 15945 20000310; SE 15946 20000310; UK PL 17901/0068-0069 20000727
1499331	SPC/GB13/034	United Kingdom		PRODUCT NAME: IZINOVA CONCENTRATE FOR ORAL SOLUTION. THE ACTIVE SUBSTANCE IS A MIXTURE OF 3 SALTS:SODIUM SULPHATE ANHYDROUS, MAGNESIUM SULPHATE HEPTAHYDRATE AND POTASSIUM SULPHATE.; REGISTERED: BE BE434323 20130220; UK PL34926/0016 20130313
0984957	122012000017	Germany		PRODUCT NAME: ASPIRIN UND ESOMEPRAZOL - MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 81047.00.00 20110930 FIRST REGISTRATION: PORTUGAL 5402359 5402367 5402375 20110812